Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Neurosurg ; 121 Suppl: 198-202, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25434953

RESUMEN

OBJECT: Glomus tumors usually display indolent behavior, and the effectiveness of radiation in stopping their growth can be assessed after long-term follow-up. Currently only midterm results of radiosurgery are available, so the authors included patients treated by Gamma Knife at least 10 years ago in this study to obtain a perspective of long-term results. METHODS: During the period from 1992 to 2003, the Gamma Knife was used to treat 46 patients with glomus tumors. The age of the patients ranged from 21 to 79 years (median 56 years). Gamma Knife radiosurgery was the primary treatment in 17 patients (37%). Open surgery preceded radiosurgery in 46% of cases, embolization in 17%, and fractionated radiotherapy in 4%. The volume of the tumor ranged from 0.2 to 24.3 cm(3) (median 3.6 cm(3)). The minimal dose to the tumor margin ranged between 10 and 30 Gy (median 20 Gy). RESULTS: One patient was lost for follow-up after radiosurgery. Clinical follow-up was available in 45 patients and 44 patients were followed with MRI in a follow-up period that ranged from 12 to 217 months (median 118 months). Neurological deficits improved in 19 (42%) of 45 patients and deteriorated in 2 patients (4%). Tumor size decreased in 34 (77%) of 44 patients with imaging follow-up, while an increase in volume was observed in 1 patient (2%) 182 months after radiosurgery and Gamma Knife treatment was repeated. One patient underwent another Gamma Knife treatment for secondary induced meningioma close to the glomus tumor 98 months after initial radiosurgical treatment. Seven patients died 22-96 months after radiosurgery (median 48 months), all for unrelated reasons. CONCLUSIONS: Radiosurgery has proved to be a safe treatment with a low morbidity rate and a reliable long-term antiproliferative effect.


Asunto(s)
Neoplasias del Oído , Tumor del Glomo Yugular , Tumor Glómico , Tumor del Glomo Timpánico , Radiocirugia/mortalidad , Adulto , Anciano , Neoplasias del Oído/mortalidad , Neoplasias del Oído/patología , Neoplasias del Oído/cirugía , Femenino , Estudios de Seguimiento , Tumor del Glomo Yugular/mortalidad , Tumor del Glomo Yugular/patología , Tumor del Glomo Yugular/cirugía , Tumor Glómico/mortalidad , Tumor Glómico/patología , Tumor Glómico/cirugía , Tumor del Glomo Timpánico/mortalidad , Tumor del Glomo Timpánico/patología , Tumor del Glomo Timpánico/cirugía , Humanos , Estimación de Kaplan-Meier , Masculino , Persona de Mediana Edad , Factores de Tiempo , Resultado del Tratamiento , Carga Tumoral , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA